Cargando…
New 3-O-substituted xanthone derivatives as promising acetylcholinesterase inhibitors
A new series of 3-O-substituted xanthone derivatives were synthesised and evaluated for their anti-cholinergic activities against acetylcholinesterase (AChE) and butyrylcholinesterase (BChE). The results indicated that the xanthone derivatives possessed good AChE inhibitory activity with eleven of t...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8759733/ https://www.ncbi.nlm.nih.gov/pubmed/33557647 http://dx.doi.org/10.1080/14756366.2021.1882452 |
_version_ | 1784633164961939456 |
---|---|
author | Loh, Zi Han Kwong, Huey Chong Lam, Kok Wai Teh, Soek Sin Ee, Gwendoline Cheng Lian Quah, Ching Kheng Ho, Anthony Siong Hock Mah, Siau Hui |
author_facet | Loh, Zi Han Kwong, Huey Chong Lam, Kok Wai Teh, Soek Sin Ee, Gwendoline Cheng Lian Quah, Ching Kheng Ho, Anthony Siong Hock Mah, Siau Hui |
author_sort | Loh, Zi Han |
collection | PubMed |
description | A new series of 3-O-substituted xanthone derivatives were synthesised and evaluated for their anti-cholinergic activities against acetylcholinesterase (AChE) and butyrylcholinesterase (BChE). The results indicated that the xanthone derivatives possessed good AChE inhibitory activity with eleven of them (5, 8, 11, 17, 19, 21-23, 26-28) exhibited significant effects with the IC(50) values ranged 0.88 to 1.28 µM. The AChE enzyme kinetic study of 3-(4-phenylbutoxy)-9H-xanthen-9-one (23) and ethyl 2-((9-oxo-9H-xanthen-3-yl)oxy)acetate (28) showed a mixed inhibition mechanism. Molecular docking study showed that 23 binds to the active site of AChE and interacts via extensive π–π stacking with the indole and phenol side chains of Trp86 and Tyr337, besides the hydrogen bonding with the hydration site and π–π interaction with the phenol side chain of Y72. This study revealed that 3-O-alkoxyl substituted xanthone derivatives are potential lead structures, especially 23 and 28 which can be further developed into potent AChE inhibitors. |
format | Online Article Text |
id | pubmed-8759733 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-87597332022-01-15 New 3-O-substituted xanthone derivatives as promising acetylcholinesterase inhibitors Loh, Zi Han Kwong, Huey Chong Lam, Kok Wai Teh, Soek Sin Ee, Gwendoline Cheng Lian Quah, Ching Kheng Ho, Anthony Siong Hock Mah, Siau Hui J Enzyme Inhib Med Chem Research Paper A new series of 3-O-substituted xanthone derivatives were synthesised and evaluated for their anti-cholinergic activities against acetylcholinesterase (AChE) and butyrylcholinesterase (BChE). The results indicated that the xanthone derivatives possessed good AChE inhibitory activity with eleven of them (5, 8, 11, 17, 19, 21-23, 26-28) exhibited significant effects with the IC(50) values ranged 0.88 to 1.28 µM. The AChE enzyme kinetic study of 3-(4-phenylbutoxy)-9H-xanthen-9-one (23) and ethyl 2-((9-oxo-9H-xanthen-3-yl)oxy)acetate (28) showed a mixed inhibition mechanism. Molecular docking study showed that 23 binds to the active site of AChE and interacts via extensive π–π stacking with the indole and phenol side chains of Trp86 and Tyr337, besides the hydrogen bonding with the hydration site and π–π interaction with the phenol side chain of Y72. This study revealed that 3-O-alkoxyl substituted xanthone derivatives are potential lead structures, especially 23 and 28 which can be further developed into potent AChE inhibitors. Taylor & Francis 2021-02-08 /pmc/articles/PMC8759733/ /pubmed/33557647 http://dx.doi.org/10.1080/14756366.2021.1882452 Text en © 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Paper Loh, Zi Han Kwong, Huey Chong Lam, Kok Wai Teh, Soek Sin Ee, Gwendoline Cheng Lian Quah, Ching Kheng Ho, Anthony Siong Hock Mah, Siau Hui New 3-O-substituted xanthone derivatives as promising acetylcholinesterase inhibitors |
title | New 3-O-substituted xanthone derivatives as promising acetylcholinesterase inhibitors |
title_full | New 3-O-substituted xanthone derivatives as promising acetylcholinesterase inhibitors |
title_fullStr | New 3-O-substituted xanthone derivatives as promising acetylcholinesterase inhibitors |
title_full_unstemmed | New 3-O-substituted xanthone derivatives as promising acetylcholinesterase inhibitors |
title_short | New 3-O-substituted xanthone derivatives as promising acetylcholinesterase inhibitors |
title_sort | new 3-o-substituted xanthone derivatives as promising acetylcholinesterase inhibitors |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8759733/ https://www.ncbi.nlm.nih.gov/pubmed/33557647 http://dx.doi.org/10.1080/14756366.2021.1882452 |
work_keys_str_mv | AT lohzihan new3osubstitutedxanthonederivativesaspromisingacetylcholinesteraseinhibitors AT kwonghueychong new3osubstitutedxanthonederivativesaspromisingacetylcholinesteraseinhibitors AT lamkokwai new3osubstitutedxanthonederivativesaspromisingacetylcholinesteraseinhibitors AT tehsoeksin new3osubstitutedxanthonederivativesaspromisingacetylcholinesteraseinhibitors AT eegwendolinechenglian new3osubstitutedxanthonederivativesaspromisingacetylcholinesteraseinhibitors AT quahchingkheng new3osubstitutedxanthonederivativesaspromisingacetylcholinesteraseinhibitors AT hoanthonysionghock new3osubstitutedxanthonederivativesaspromisingacetylcholinesteraseinhibitors AT mahsiauhui new3osubstitutedxanthonederivativesaspromisingacetylcholinesteraseinhibitors |